WPWM
WST icon

Western Pacific Wealth Management’s West Pharmaceutical WST Stock Holding History

Western Pacific Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.2K Buy
+254
New +$77.7K 0.08% 100
2025
Q3 		– Sell
-166
Closed -$36.3K – 205
2025
Q2 		$36.3K Hold
166
– – 0.03% 147
2025
Q1 		$37.2K Sell
166
-93
-36% -$25.6K 0.03% 138
2024
Q4 		$84.8K Buy
+259
New +$81.5K 0.07% 114

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Western Pacific Wealth Management's WST Position: Q2 2026 in Review

Western Pacific Wealth Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 254 shares worth $91.2K. The stake represents 0.08% of the portfolio and ranks #100 among its holdings. This is a return to the name: Western Pacific Wealth Management previously reported a position in WST as recently as Q2 2025.

Western Pacific Wealth Management first reported a position in WST in Q4 2024 and has held it in 4 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Western Pacific Wealth Management held 254 shares of West Pharmaceutical worth $91.2K as of Q2 2026.
  • West Pharmaceutical was a new Western Pacific Wealth Management position in Q2 2026.
  • West Pharmaceutical made up 0.08% of Western Pacific Wealth Management's portfolio in Q2 2026, its #100 holding.
  • Western Pacific Wealth Management first reported a position in West Pharmaceutical in Q4 2024 and has held it in 4 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Western Pacific Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.